Advertisement

Klinische Neuropathologie des Parkinson-Syndroms — Proteintyp und Dopamintyp der Demelaninisierung

  • H. Jacob
  • T. Kawagoe

Zusammenfassung

Die neuronale Zytopathologie des Parkinsonismus interessiert ätiopathogenetisch besonders im Hinblick auf morphologisch-biochemische Strukturbeziehungen. Demgegenüber ist ihre zentralnervöse Topologie für die klinisch-neurologische Symptombildung von Bedeutung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agnoli A (1980) Aging and extrapyramidal Syndromes (Parkinsonism). In: Barbagallo-Sangiorg G (ed) The aging brain, Vol 5. Plenum Press, New York LondonGoogle Scholar
  2. Alvord ED, Forno L, Kusske JA, Kaufmann RJ (1974) The pathology of parkinsonism. A comparison of degeneration in cerebral cortex and brain System. Adv Neurol 5:175–193PubMedGoogle Scholar
  3. AndrÉ JM, Royer RJ, Due M, Kissel P (1974) Analyse d’un échec thérapeutique de la L-Dopa. Rev Neurol 130:322–326PubMedGoogle Scholar
  4. Andrews JM, Terry RD, Spataro J (1970) Arch Neurol 23:319–329PubMedGoogle Scholar
  5. Bagh K von (1946) Über anatomische Befunde bei 30 Fällen von systematischer Atrophie der Großhirnrinde. Ann Acad Sci Fenn A 5/10:1–132Google Scholar
  6. Bazelon M, Fenichel GM, Ino Randall BA (1967) Studies in neuromelanin. I: A melanin System in human adult brainstem. Neurology 17/1:512–519Google Scholar
  7. Bethlem J, den Hartog Jager NA (1960) The incidence and characteristics of Lewy-bodies in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:74–80PubMedCrossRefGoogle Scholar
  8. Duffy PF, Tennyson VM (1965) Phase and electron microscopic observations of the Lewy-bodies and melanin-granules in the substantia nigra and locus coeruleus in Parkinson’s disease. J Neuropathol Exp Neurol 24:398–414CrossRefGoogle Scholar
  9. Fahn S (1976) Biochemistry of the basal ganglia. Adv Neurol 14:59–89PubMedGoogle Scholar
  10. Fahn S (1977) Parkinson’s Disease In: Goldensohn ES, Appel S (eds). Scientific (Appr.) to clinical Neurology. Lea & Febiger, Philadelphia, pp 1119–1158Google Scholar
  11. Fahn S, Duffy P (1977) The role of bromocriptin in the treatment of Parkinsonism. Neurology 29:1077–1083Google Scholar
  12. Feve JR, Mussini JM, MathÉ JF, Cler JM, Nomballais MF (1977) Dégénérescence striato-nigrique. Rev Neurol 133/4:271–278Google Scholar
  13. Fischer P-A, Jacobi P, Schneider E, Becker H (1976) Correlation between clinical and CT-fmdings in Parkinson’s Syndrome. In: Lanksch N, Kazner E (eds) Computerized tomography. Springer, Berlin Heidelberg New York, pp 244–248Google Scholar
  14. FoIx C, Nicolesco J (1925) Les noyaux gris centraux et la région mésencephalo-sous-thalamique. Masson, ParisGoogle Scholar
  15. Foley JM, Baxter D (1958) On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra. J Neuropathol Exp Neurol 17:586–589PubMedCrossRefGoogle Scholar
  16. Forno LS (1971) The pathology of Parkinsonism. In: Dowell FH, Markham CH (eds) Rec. Advanc in Parkinson’s disease. Davis Philadelphia, pp 119–161Google Scholar
  17. Forno LS (1974) Depigmentation in the nerve cells of the substantia nigra and locus coeruleus in Parkinsonism. Adv Neurol 5:195–202PubMedGoogle Scholar
  18. Forno LS, Strefling AM, Sternberger LA, Sternberger NH, Eng LF (1983) Immunocytochemical staining of neurofibrillary tangles and of the periphery of lewy bodies with a monoclonal antibody to neurofilaments. Am Assoc Neuropathol-Abstracts of the 59. Annual Meeting, St. Louis N 111Google Scholar
  19. Gambetti P, Shecket G, Ghetti B, Hirano A, Dahl P (1983) Neurofibrillary changes in human brain. J Neuropathol Exp Neurol 42/1:69–79CrossRefGoogle Scholar
  20. Gellerstedt F (1933) Zur Kenntnis der Hirnveränderungen bei der normalen Altersinvolution. Inaug.-Diss. UppsallaGoogle Scholar
  21. Goldman JE, Yen SH, Chiu FC, Pereos NS (1983) Neurofilament antibodies react with Lewy bodies. Am Assoc Neuropathol-Abstracts of the 59th Annual Meeting St. Louis N 86Google Scholar
  22. Hassler R (1937) Zur Normalanatomie des Substantia nigra. J Psychol Neurol 48/1:1–55Google Scholar
  23. Ikeda K, Ikeda S, Yoshimura T, Kato H, Namba M (1978) Idiopathic Parkinsonism with Lewy-typ inclusions in cerebral cortex. Acta Neuropathol 41:165–168PubMedCrossRefGoogle Scholar
  24. Jacob H (1960) Differentialdiagnose perniciöser Involutionspsychosen, präseniler Psychosen und Psychosen bei Involutionspellagra. Arch Psychiatr Nervenkr 201:17–52CrossRefGoogle Scholar
  25. Jacob H (1967) Zur klinisch-neuropathologischen Differentialdiagnose präsenil-involutiver Erkrankungen des Zentralnervensystems. Acta Neuropathol (Suppl) 3:110–118Google Scholar
  26. Jacob H (1971) Extrapyramidal-pyramidal-akinetische Syndrome bei progressiven Encephalopathien mit achromatischen Nervenzellschwellungen und Zellgliosen im höheren Lebensalter. Acta Neuropathol 17:341–352PubMedCrossRefGoogle Scholar
  27. Jacob H (1978) Neuropathologie des Parkinson-Syndroms und die Senescenz des Gehirns. In: Fischer PA (Hrsg) Langzeitbehandlung des Parkinson-Syndroms. Schattauer, Stuttgart New YorkGoogle Scholar
  28. Jacob H (1982a) Neuropathologie des Parkinson-Syndroms und Seneszenz des Gehirns. In: Pfeiffer EF (Hrsg) Bromocriptin. Ein fachübergreifendes Therapieprinzip. 8. Rothenburger Gespräch 21./22. Mai 1981. Schattauer, Stuttgart New York S 87–98Google Scholar
  29. Jacob H (1982 b) Lokalisation neuropathologischer Prozesse und klinische Symptomatik. Neuropa-thologica (Jpn) 3:77–94Google Scholar
  30. Jacob H (1983) Klinische Neuropathologie des Parkinsonismus. 13. Zentraleuropäisches Symposion, Heidelberg. Roche, BaselGoogle Scholar
  31. Jellinger K (1974) Pathomorphologie des Parkinson-Syndroms. Aktuel Neurol 1:83–98Google Scholar
  32. Kaiya H, Yoshimura T, Namba M (1977) Cortico-cerebello-thalamic degeneration with chromatolytic neuronal swelling. Folia Psychiatr Neurol (Jpn) 5:292–311Google Scholar
  33. Kosaka K, Oyanagi S, Matsushita M, Hori A, Iwase S (1976) Presenile dementia with Alzheimer-,Pick-and Lewy-bodies. Acta Neuropathol 36:221–233PubMedCrossRefGoogle Scholar
  34. Kosaka K, Mehraein P (1979) Dementia-Parkinsonism-syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 226:241–250PubMedCrossRefGoogle Scholar
  35. Kosaka K, Matsushita M, Oyanagi S, Mehraein P (1982 a) A clinico neuropathological study in Lewy-bodies disease. Psychiatr Neurol (Jpn) 5:292–311Google Scholar
  36. Kosaka K, Yoshimura M, Ikeda K, Seitelberger F (1982 b) Diffuse Type of Lewy-body disease. IX. Int. Congr. of Neuropathology, WienGoogle Scholar
  37. Lust WD, Mrsulja BB, Passoneau JV, Klatzo I (1975) Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex. Brain Res 98:349–399CrossRefGoogle Scholar
  38. Maeda S, Yokoi S, Isaka K (1973) An unusual type of familial extrapyramidal disease: Cortico-striato-pallido-nigral degeneration. Psychiatr Neurol (Jpn) 75:657–672Google Scholar
  39. Mann DMA, Yates PO, Barton CM (1977) Neuromelanin and RNA in cells of the substantia nigra. J Neuropathol Exp Neurol 36:379–383PubMedCrossRefGoogle Scholar
  40. Mann DMA, Yates PO (1979) Effects of ageing in the pigmented nerve cells of the human locus coeruleus and substantia nigra. Acta Neuropathol 47:93–97PubMedCrossRefGoogle Scholar
  41. Mann DMA, Yates PO (1982) Pathogenesis of Parkinson’s disease. Arch Neurol 39:545–549PubMedGoogle Scholar
  42. McGeer EC, McGeer PL, Suzuki JS (1977) Ageing and extrapyramidal function. Arch Neurol 34:33–35PubMedGoogle Scholar
  43. Michel D, Tommasi M, Laurent B, Trillet M, Schott B (1976) Dégénérescence striato-nigrique. Rev Neurol 132:3–22PubMedGoogle Scholar
  44. Rajput AH (1972) Striato-nigral degeneration-Response to levodopa therapy. J Neurol Sci 16:331–341PubMedCrossRefGoogle Scholar
  45. Riederer P, Jellinger K (1980) Zur Bedeutung der Senescenz zerebraler Neurotransmitter für das Parkinson-Syndrom. In: Fischer PA (Hrsg) Parkinson-Syndrom: Kombinations-und Begleittherapien. Schattauer, Stuttgart New YorkGoogle Scholar
  46. Rebeiz JJ, Kolodny EH, Richardson E (1968) Cortico-dentato-nigral degeneration with neuronal achromasia. Arch Neurol (Chic) 18:20–33Google Scholar
  47. Schneider E, Fischer P-A, Becker H, Hacker H, Pencz A, Jacobi P (1977) Relationship between arteriosclerotic and cerebral atrophy in Parkinson’s disease. Neurology 217:11–16CrossRefGoogle Scholar
  48. Schneider E, Fischer P-A, Jacobi P, Becker H (1978) Zur Relevanz extranigraler Hirnläsionen bei Parkinson-Kranken. In: Fischer P-A (Hrsg) Langzeitbehandlung des Parkinson-Syndroms. Schattauer, Stuttgart New YorkGoogle Scholar
  49. Seitelberger F (1975) Achromatic neuronal dystrophy. VII. Internat Congr. of Neuropathol. 1974, Vol I. Excerpta Medica, AmsterdamGoogle Scholar
  50. Sharpe JA, Rewcastle NB, Lloyd KG, Hornykiewicz O, Hill M, Tasker RR (1973) Striato-nigral degeneration. J Neurolog Sci 19:275–286CrossRefGoogle Scholar
  51. TakÁts A (1982) Neuropathological examination of 57 Parkinson patients. IX. Int. Congr. of Neuro-pathology, Wien, p 115Google Scholar
  52. Tomonaga M (1981) Neuroflbrillary tangles and Lewy-bodies in the locus coeruleus of the aged brain. Acta Neuropathol 53:165PubMedCrossRefGoogle Scholar
  53. Williams HW (1935) The peculiar cells of Pick’s disease. Arch Neurol 34:508–519Google Scholar
  54. Woodard JS (1962) Concentric hyaline inclusion body formation in mental disease analysis of 27 cases. J Neuronath Exp Neurol 21/3: 442–449CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin-Heidelberg 1984

Authors and Affiliations

  • H. Jacob
  • T. Kawagoe

There are no affiliations available

Personalised recommendations